Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Drug Research
Drug Discovery & Development
Return to: PBR Home | Drug Research | Drug Discovery & Development | News
Search Refinements

Drug Discovery & Development News

View news from other Pharmaceutical sectors:
121-135 of 4468 results
Ferring, Enteris to develop oral formulation of peptide-based injectable therapeutic
Ferring Pharmaceuticals and Enteris BioPharma have signed a license agreement to develop an oral formulation of a peptide-based injectable therapeutic.
Drug Research > Drug Discovery & Development > News
Biscayne Neurotherapeutics raises $3m for antiepileptic compound
Biscayne Pharmaceuticals has raised financing for its new spin-out, Biscayne Neurotherapeutics, which was recently established to develop its biopharmaceutical assets for the treatment of neurological disorders.
Drug Research > Drug Discovery & Development > News
Celgene to buy biotechnology company Delinia
Celgene has agreed to acquire Delinia, a biotechnology company developing novel therapeutics for the treatment of autoimmune diseases.
Drug Research > Drug Discovery & Development > News
Johnson & Johnson to buy Actelion for $30bn
By PBR Staff Writer
US healthcare giant Johnson & Johnson (J&J) has agreed to acquire Swiss biopharmaceutical firm Actelion for $30bn.
Drug Research > Drug Discovery & Development > News
Connect secures $25m financing to advance immune modulators clinical development
Connect Biopharmaceuticals has completed a $20m Series A financing to advance clinical development of novel immune modulators.
Drug Research > Drug Discovery & Development > News
Discuva secures Innovate UK grant for new antibiotics development
Innovate UK has awarded a £1.5m Biomedical Catalyst early-stage award to drug discovery firm Discuva for the development of novel antibiotics to tackle the issue of multidrug-resistance and life-threatening bacterial infections.
Drug Research > Drug Discovery & Development > News
Cue Biopharma raises $26M in funding
Cue Biopharma has announced a total of $26m of invested private capital, led by MDB Capital Group, to develop next-generation biologics to selectively control T Cell activity.
Drug Research > Drug Discovery & Development > News
ELC Group partners with PSR Group for advanced drug development
Global life sciences partner ELC Group is collaborating with New Zealand-based research and development firm Pharma Scientific Research (PSR Group) to create highly advanced products for the pharmaceutical market.
Drug Research > Drug Discovery & Development > News
Merck, Domain Therapeutics partner to co-develop adenosine receptor antagonists
Merck has entered into a collaboration and licensing agreement with French based Domain Therapeutics to explore the potential of adenosine inhibition in the development of novel immuno-oncology agents.
Drug Research > Drug Discovery & Development > News
Cytori to buy Azaya’s nanoparticle Development Platform
By PBR Staff Writer
Cytori Therapeutics has agreed to acquire certain assets from oncology firm Azaya Therapeutics in a deal potentially worth $170m.
Drug Research > Drug Discovery & Development > News
Ethypharm agrees to acquire UK-based Martindale Pharma
Ethypharm has agreed to acquire Martindale Pharma, a UK-based specialty pharmaceutical firm offering essential medicines to more than 50 countries across the world.
Drug Research > Drug Discovery & Development > News
Takeda, Ovid to co-develop rare pediatric epilepsy candidate TAK-935
Takeda Pharmaceutical said its rare pediatric epilepsy candidate TAK-935 will be co-developed through a partnership with Ovid Therapeutics.
Drug Research > Drug Discovery & Development > News
Horizon Discovery broadens gene editing capabilities
Horizon Discovery Group has expanded its gene editing capabilities through the amendment of a pre-existing license with ERS Genomics to include the full commercial rights for the use of CRISPR edited cell lines for the Good Manufacturing Practice (GMP) manufacturing of biotherapeutics.
Drug Research > Drug Discovery & Development > News
Malin buys 33% interest in UK's Wren Therapeutics
By PBR Staff Writer
Irish life sciences firm Malin has acquired a 33% stake in UK biopharmaceutical company, Wren Therapeutics.
Drug Research > Drug Discovery & Development > News
Aptevo Therapeutics receives $20m payment from Emergent BioSolutions
Aptevo Therapeutics has received a $20m cash payment from Emergent BioSolutions pursuant to a promissory note granted as a result of the spin-off of Aptevo from Emergent, effective August 1, 2016.
Drug Research > Drug Discovery & Development > News
121-135 of 4468 results